Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Pain is a Tricky Thing to Treat, or Even Evaluate
Rheumatology is such a gratifying and emotionally rewarding medical specialty. There is no better feeling than helping patients with conditions whose proper diagnosis and management have eluded other practitioners. A patient with diffuse idiopathic skeletal hyperostosis (DISH) presents with pain, and a major clinical tenet of DISH has been its lack of association with pain.
New Diagnostic Criteria for Axial Spondylarthritis
New name and classification criteria for ankylosing spondylitis may help with earlier diagnosis and treatment.
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety
Coding Corner Question
December’s Coding Challenge
Researcher Looks at Link between Arthritis and Eye Disease
Holly Rosenzweig, PhD, has developed a novel investigative model that may better inform treatment of patients with ankylosing spondylitis (AS) who also develop uveitis.
“A Common Language for Spondyloarthritis”
ASAS fills a niche, changes dogma with consensus approach
No Clear Connection Between Inflammation & Disease Progression in AS
TNF blockers decrease symptoms but seem to have little impact on structural damage
Reading Rheum
Handpicked Reviews of Contemporary Literature
State-of-the-Art Clinical Symposium
The 2008 ACR State-of-the-Art Clinical Symposium will present current, cutting-edge information on a broad array of topics in rheumatology.